Drug pricing debates: Can we quantify what a life’s worth? Posted on October 11, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biopharmaceutical, Biotech, Drug Costs, Health Policy, Pharmaceuticals, Quality of Life • Leave a comment Drug pricing debates: Can we quantify what a life’s worth? Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading... Related
HENRY KOTULA 